These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 23238907

  • 1. Multisite, double-blind, randomized, controlled study of pregabalin for essential tremor.
    Zesiewicz TA, Sullivan KL, Hinson V, Stover NP, Fang J, Jahan I, Miller A, Carranza MA, Elble R.
    Mov Disord; 2013 Feb; 28(2):249-50. PubMed ID: 23238907
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trial.
    Ferrara JM, Kenney C, Davidson AL, Shinawi L, Kissel AM, Jankovic J.
    J Neurol Sci; 2009 Oct 15; 285(1-2):195-7. PubMed ID: 19631949
    [Abstract] [Full Text] [Related]

  • 3. A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor.
    Zesiewicz TA, Ward CL, Hauser RA, Salemi JL, Siraj S, Wilson MC, Sullivan KL.
    Mov Disord; 2007 Aug 15; 22(11):1660-3. PubMed ID: 17580330
    [Abstract] [Full Text] [Related]

  • 4. Pregabalin (Lyrica) in the treatment of essential tremor.
    Zesiewicz TA, Ward CL, Hauser RA, Pease Campbell JA, Sullivan KL.
    Mov Disord; 2007 Jan 15; 22(1):139-41. PubMed ID: 17089400
    [Abstract] [Full Text] [Related]

  • 5. Essential tremor in the older adult: coping with primary symptoms.
    Luggen AS, National Conference of Gerontological Nurse Practitioners.
    Adv Nurse Pract; 2004 Sep 15; 12(9):32-6. PubMed ID: 15473446
    [No Abstract] [Full Text] [Related]

  • 6. New alternative agents in essential tremor therapy: double-blind placebo-controlled study of alprazolam and acetazolamide.
    Gunal DI, Afşar N, Bekiroglu N, Aktan S.
    Neurol Sci; 2000 Oct 15; 21(5):315-7. PubMed ID: 11286044
    [Abstract] [Full Text] [Related]

  • 7. Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials.
    Connor GS, Edwards K, Tarsy D.
    Clin Neuropharmacol; 2008 Oct 15; 31(2):97-103. PubMed ID: 18382182
    [Abstract] [Full Text] [Related]

  • 8. The effects of TPA023, a GABAAα2,3 subtype-selective partial agonist, on essential tremor in comparison to alcohol.
    de Haas SL, Zoethout RW, Van Dyck K, De Smet M, Rosen LB, Murphy MG, Gottesdiener KM, Schoemaker RC, Cohen AF, van Gerven JM.
    J Psychopharmacol; 2012 Feb 15; 26(2):282-91. PubMed ID: 21890585
    [Abstract] [Full Text] [Related]

  • 9. Pregabalin for peripheral neuropathic pain: a multicenter, enriched enrollment randomized withdrawal placebo-controlled trial.
    Gilron I, Wajsbrot D, Therrien F, Lemay J.
    Clin J Pain; 2011 Feb 15; 27(3):185-93. PubMed ID: 21178603
    [Abstract] [Full Text] [Related]

  • 10. A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor.
    Zesiewicz TA, Ward CL, Hauser RA, Sanchez-Ramos J, Staffetti JF, Sullivan KL.
    Mov Disord; 2007 Jan 15; 22(2):279-82. PubMed ID: 17149715
    [Abstract] [Full Text] [Related]

  • 11. Effect of pregabalin on sleep in patients with fibromyalgia and sleep maintenance disturbance: a randomized, placebo-controlled, 2-way crossover polysomnography study.
    Roth T, Lankford DA, Bhadra P, Whalen E, Resnick EM.
    Arthritis Care Res (Hoboken); 2012 Apr 15; 64(4):597-606. PubMed ID: 22232085
    [Abstract] [Full Text] [Related]

  • 12. An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia.
    Pauer L, Winkelmann A, Arsenault P, Jespersen A, Whelan L, Atkinson G, Leon T, Zeiher B, A0081100 Investigators.
    J Rheumatol; 2011 Dec 15; 38(12):2643-52. PubMed ID: 21965636
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of amantadine in essential tremor: a randomized, placebo-controlled trial.
    Gironell A, Kulisevsky J, Pascual-Sedano B, Flamarich D.
    Mov Disord; 2006 Apr 15; 21(4):441-5. PubMed ID: 16229019
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of pregabalin in preventing relapse in patients with generalized social anxiety disorder: results of a double-blind, placebo-controlled 26-week study.
    Greist JH, Liu-Dumaw M, Schweizer E, Feltner D.
    Int Clin Psychopharmacol; 2011 Sep 15; 26(5):243-51. PubMed ID: 21734588
    [Abstract] [Full Text] [Related]

  • 17. Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial.
    Hadley SJ, Mandel FS, Schweizer E.
    J Psychopharmacol; 2012 Apr 15; 26(4):461-70. PubMed ID: 21693549
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A randomized, double-blind, 6-week, dose-ranging study of pregabalin in patients with restless legs syndrome.
    Allen R, Chen C, Soaita A, Wohlberg C, Knapp L, Peterson BT, García-Borreguero D, Miceli J.
    Sleep Med; 2010 Jun 15; 11(6):512-9. PubMed ID: 20466589
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y, Ding X, Cheng Y, Fan D, Tan L, Wang Y, Zhao Z, Hong Z, Zhou D, Pan X, Chen S, Martin A, Tang H, Cui L.
    Clin Ther; 2011 Feb 15; 33(2):159-66. PubMed ID: 21444113
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.